Maynard Um
-
-
-
-
-
-
-
Century Therapeutics (IPSC) PT Raised to $4 at Piper Sandler
-
-
-
-
-
-
-
Century Therapeutics (IPSC) Files $200M Mixed Shelf
-
-
-
-
-
-
-
Century Therapeutics (IPSC) Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned
-
-
-
-
-
-
-
Century Therapeutics (IPSC) PT Raised to $12 at Piper Sandler
397,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

